{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:50:02Z","timestamp":1791669002211,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"RECOOP HST Association","award":["RECOOP Research Grant #024"],"award-info":[{"award-number":["RECOOP Research Grant #024"]}]},{"name":"Ministry of Health of Ukraine","award":["#0121U100305"],"award-info":[{"award-number":["#0121U100305"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03404-2","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:32:19Z","timestamp":1791667939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Severity-associated endothelial dysfunction in post-COVID-19 patients: flow-mediated dilation and vasoactive biomarkers"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3305-6265","authenticated-orcid":false,"given":"Svitlana M.","family":"Palii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6787-4843","authenticated-orcid":false,"given":"Boryslav","family":"Selskyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7963-5425","authenticated-orcid":false,"given":"Svyatoslav","family":"Kostiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0810-9444","authenticated-orcid":false,"given":"Anastasia","family":"Voitovych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5328-4647","authenticated-orcid":false,"given":"Kateryna","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2473-6381","authenticated-orcid":false,"given":"Oksana","family":"Shevchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0676-336X","authenticated-orcid":false,"given":"Mykhaylo","family":"Korda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2962-2017","authenticated-orcid":false,"given":"Sandor G.","family":"Vari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"issue":"1","key":"3404_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/v13010029","volume":"13","author":"I Bernard","year":"2020","unstructured":"Bernard I, Limonta D, Mahal L, Hobman T (2020) Endothelium infection and dysregulation by SARS-CoV-2: evidence and caveats in COVID-19. Viruses 13(1):29. https:\/\/doi.org\/10.3390\/v13010029","journal-title":"Viruses"},{"issue":"2","key":"3404_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3390\/covid1020042","volume":"1","author":"HK Al-Hakeim","year":"2021","unstructured":"Al-Hakeim HK, Al-Hamami SA, Almulla AF, Maes M (2021) Increased Serum Thromboxane A2 and Prostacyclin but Lower Complement C3 and C4 Levels in COVID-19: Associations with Chest CT Scan Anomalies and Lowered Peripheral Oxygen Saturation. COVID 1(2):489\u2013502. https:\/\/doi.org\/10.3390\/covid1020042","journal-title":"COVID"},{"key":"3404_CR3","doi-asserted-by":"publisher","first-page":"106356","DOI":"10.1016\/j.rmed.2021.106356","volume":"180","author":"S Samadizadeh","year":"2021","unstructured":"Samadizadeh S, Masoudi M, Rastegar M, Salimi V, Shahbaz MB, Tahamtan A (2021) COVID-19: Why does disease severity vary among individuals? Respir Med 180:106356. https:\/\/doi.org\/10.1016\/j.rmed.2021.106356","journal-title":"Respir Med"},{"key":"3404_CR4","doi-asserted-by":"publisher","first-page":"106975","DOI":"10.1016\/j.vph.2022.106975","volume":"144","author":"E Oikonomou","year":"2022","unstructured":"Oikonomou E, Souvaliotis N, Lampsas S, Siasos G, Poulakou G, Theofilis P et al (2022) Endothelial dysfunction in acute and long standing COVID\u2009\u2013\u200919: A prospective cohort study. Vascul Pharmacol 144:106975. https:\/\/doi.org\/10.1016\/j.vph.2022.106975","journal-title":"Vascul Pharmacol"},{"issue":"4","key":"3404_CR5","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/life15040520","volume":"15","author":"D Loboda","year":"2025","unstructured":"Loboda D, Golba KS, Gurowiec P, Bredelyt\u0117 A, Razbadauskas A, Sarecka-Hujar B (2025) Variability in arterial stiffness and vascular endothelial function after COVID-19 during 1.5 years of follow-up\u2014systematic review and meta-analysis. Life 15(4):520. https:\/\/doi.org\/10.3390\/life15040520","journal-title":"Life"},{"key":"3404_CR6","doi-asserted-by":"publisher","unstructured":"Mavraganis G, Dimopoulou M, Delialis D, Bampatsias D, Patras R, Sianis A et al (2022) Clinical implications of vascular dysfunction in acute and convalescent COVID-19: A systematic review. Eur J Clin Invest 52(11). https:\/\/doi.org\/10.1111\/eci.13859","DOI":"10.1111\/eci.13859"},{"issue":"4","key":"3404_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41401-022-00998-0","volume":"44","author":"S Xu","year":"2023","unstructured":"Xu S, Ilyas I, Weng J (2023) Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol Sin 44(4):695\u2013709. https:\/\/doi.org\/10.1038\/s41401-022-00998-0","journal-title":"Acta Pharmacol Sin"},{"key":"3404_CR8","doi-asserted-by":"publisher","unstructured":"Wang X, He B (2024) Endothelial dysfunction: molecular mechanisms and clinical implications. MedComm 5(8). https:\/\/doi.org\/10.1002\/mco2.651","DOI":"10.1002\/mco2.651"},{"issue":"3","key":"3404_CR9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s12975-020-00818-9","volume":"11","author":"DC Hess","year":"2020","unstructured":"Hess DC, Eldahshan W, Rutkowski E (2020) COVID-19-related stroke. Transl Stroke Res 11(3):322\u2013325. https:\/\/doi.org\/10.1007\/s12975-020-00818-9","journal-title":"Transl Stroke Res"},{"issue":"10","key":"3404_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41577-022-00762-9","volume":"22","author":"EM Conway","year":"2022","unstructured":"Conway EM, Mackman N, Warren RQ, Wolberg AS, Mosnier LO, Campbell RA et al (2022) Understanding COVID-19-associated coagulopathy. Nat Rev Immunol 22(10):639\u2013649. https:\/\/doi.org\/10.1038\/s41577-022-00762-9","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"3404_CR11","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3390\/biomedicines11041181","volume":"11","author":"AA Farooqui","year":"2023","unstructured":"Farooqui AA, Farooqui T, Sun GY, Lin T-N, Teh DBL, Ong W-Y (2023) COVID-19, Blood Lipid Changes, and Thrombosis. Biomedicines 11(4):1181. https:\/\/doi.org\/10.3390\/biomedicines11041181","journal-title":"Biomedicines"},{"issue":"10234","key":"3404_CR12","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395(10234):1417\u20131418. https:\/\/doi.org\/10.1016\/S0140-6736(20)30937-5","journal-title":"Lancet"},{"issue":"1","key":"3404_CR13","doi-asserted-by":"publisher","first-page":"2001634","DOI":"10.1183\/13993003.01634-2020","volume":"56","author":"A Huertas","year":"2020","unstructured":"Huertas A, Montani D, Savale L, Pichon J, Tu L, Parent F et al (2020) Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J 56(1):2001634. https:\/\/doi.org\/10.1183\/13993003.01634-2020","journal-title":"Eur Respir J"},{"issue":"10","key":"3404_CR14","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","volume":"115","author":"JE Deanfield","year":"2007","unstructured":"Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction. Circulation 115(10):1285\u20131295. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.652859","journal-title":"Circulation"},{"issue":"6","key":"3404_CR15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.4161\/viru.24530","volume":"4","author":"AV Page","year":"2013","unstructured":"Page AV, Liles WC (2013) Biomarkers of endothelial activation\/dysfunction in infectious diseases. Virulence 4(6):507\u2013516. https:\/\/doi.org\/10.4161\/viru.24530","journal-title":"Virulence"},{"issue":"4","key":"3404_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/SHK.0000000000001660","volume":"55","author":"MA Mazzeffi","year":"2021","unstructured":"Mazzeffi MA, Chow JH, Tanaka K (2021) COVID-19 Associated Hypercoagulability: Manifestations, Mechanisms, and Management. Shock 55(4):465\u2013471. https:\/\/doi.org\/10.1097\/SHK.0000000000001660","journal-title":"Shock"},{"issue":"1","key":"3404_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/cvr\/cvac095","volume":"119","author":"C Heiss","year":"2023","unstructured":"Heiss C, Rodriguez-Mateos A, Bapir M, Skene SS, Sies H, Kelm M (2023) Flow-mediated dilation reference values for evaluation of endothelial function and cardiovascular health. Cardiovasc Res 119(1):283\u2013293. https:\/\/doi.org\/10.1093\/cvr\/cvac095","journal-title":"Cardiovasc Res"},{"key":"3404_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/453264","volume":"2012","author":"M Miyamoto","year":"2012","unstructured":"Miyamoto M, Kotani K, Ishibashi S, Taniguchi N (2012) The Effect of Antihypertensive Drugs on Endothelial Function as Assessed by Flow-Mediated Vasodilation in Hypertensive Patients. Int J Vasc Med 2012:1\u201311. https:\/\/doi.org\/10.1155\/2012\/453264","journal-title":"Int J Vasc Med"},{"issue":"2","key":"3404_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2174\/0115734021280797240212091416","volume":"20","author":"SM Arabi","year":"2024","unstructured":"Arabi SM, Chambari M, Bahrami LS, Hadi S, Sahebkar A (2024) Statin Therapy and Flow-Mediated Dilation: A Systematic Review and Dose-Response Meta-Analysis Using the GRADE of Data from Randomized Controlled Trials. Curr Hypertens Rev 20(2):90\u2013100. https:\/\/doi.org\/10.2174\/0115734021280797240212091416","journal-title":"Curr Hypertens Rev"},{"issue":"12","key":"3404_CR20","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.3390\/cells11121972","volume":"11","author":"D Zha","year":"2022","unstructured":"Zha D, Fu M, Qian Y (2022) Vascular endothelial glycocalyx damage and potential targeted therapy in COVID-19. Cells 11(12):1972. https:\/\/doi.org\/10.3390\/cells11121972","journal-title":"Cells"},{"issue":"9","key":"3404_CR21","doi-asserted-by":"publisher","first-page":"e0194","DOI":"10.1097\/CCE.0000000000000194","volume":"2","author":"DD Fraser","year":"2020","unstructured":"Fraser DD, Patterson EK, Slessarev M, Gill SE, Martin C, Daley M et al (2020) Endothelial injury and glycocalyx degradation in critically Ill coronavirus disease 2019 patients: implications for microvascular platelet aggregation. Crit Care Explor 2(9):e0194. https:\/\/doi.org\/10.1097\/CCE.0000000000000194","journal-title":"Crit Care Explor"},{"issue":"10","key":"3404_CR22","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00424-022-02726-3","volume":"474","author":"B Fels","year":"2022","unstructured":"Fels B, Acharya S, Vahldieck C, Graf T, K\u00e4ding N, Rupp J et al (2022) Mineralocorticoid receptor-antagonism prevents COVID-19-dependent glycocalyx damage. Pfl\u00fcgers Arch - Eur J Physiol 474(10):1069\u20131076. https:\/\/doi.org\/10.1007\/s00424-022-02726-3","journal-title":"Pfl\u00fcgers Arch - Eur J Physiol"},{"issue":"35","key":"3404_CR23","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.2174\/138161208786898761","volume":"14","author":"L Ghiadoni","year":"2008","unstructured":"Ghiadoni L, Versari D, Giannarelli C, Faita F, Taddei S (2008) Non-invasive diagnostic tools for investigating endothelial dysfunction. Curr Pharm Des 14(35):3715\u20133722. https:\/\/doi.org\/10.2174\/138161208786898761","journal-title":"Curr Pharm Des"},{"issue":"1","key":"3404_CR24","doi-asserted-by":"publisher","first-page":"H2","DOI":"10.1152\/ajpheart.00471.2010","volume":"300","author":"DHJ Thijssen","year":"2011","unstructured":"Thijssen DHJ, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA et al (2011) Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Circ Physiol 300(1):H2\u201312. https:\/\/doi.org\/10.1152\/ajpheart.00471.2010","journal-title":"Am J Physiol Circ Physiol"},{"key":"3404_CR25","unstructured":"World Health Organization SARS-CoV-2 Delta variant now dominant in much of European region; efforts must be reinforced to prevent transmission, warns WHO Regional Office for Europe and ECDC. 23 July. 2021 [cited 2025 Jun 16]. Available from: https:\/\/www.who.int\/europe\/news-room\/22-07-2021-sars-cov-2-delta-variant-now-dominant-in-much-of-european-region-efforts-must-be-reinforced-to-prevent-transmission-warns-who-regional-office-for-europe-and-ecdc"},{"key":"3404_CR26","unstructured":"\u0420\u043e\u0431\u043e\u0447\u0430 \u0433\u0440\u0443\u043f\u0430 \u0437 \u043e\u043f\u0440\u0430\u0446\u044e\u0432\u0430\u043d\u043d\u044f \u043a\u043b\u0456\u043d\u0456\u0447\u043d\u043e\u0457 \u043d\u0430\u0441\u0442\u0430\u043d\u043e\u0432\u0438 \u041a\u043b\u0456\u043d\u0456\u0447\u043d\u0435 \u0432\u0435\u0434\u0435\u043d\u043d\u044f \u043f\u0430\u0446\u0456\u0454\u043d\u0442\u0456\u0432 \u0437 COVID-19. \u00ab\u0416\u0438\u0432\u0430\u00bb \u043a\u043b\u0456\u043d\u0456\u0447\u043d\u0430 \u043d\u0430\u0441\u0442\u0430\u043d\u043e\u0432\u0430, 2021 [Clinical management of patients with COVID-19. Living clinical guideline, 2021]. [cited 2025 Jun 17] Available from: http:\/\/cp-medical.com\/downloads\/2021_03_kn_covid-19.pdf [In Ukrainian]"},{"key":"3404_CR27","unstructured":"World Health Organization. Country & technical guidance - coronavirus disease (COVID-19) (2020) [cited 2025 Jun 16] Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/technical-guidance"},{"issue":"2","key":"3404_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ejvs.2022.06.022","volume":"63","author":"MG De Maeseneer","year":"2022","unstructured":"De Maeseneer MG, Kakkos SK, Aherne T, Baekgaard N, Black S, Blomgren L et al (2022) European society for vascular surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs. Eur J Vasc Endovasc Surg 63(2):184\u2013267. https:\/\/doi.org\/10.1016\/j.ejvs.2022.06.022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"3404_CR29","unstructured":"World Health Organization (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation"},{"issue":"1","key":"3404_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.vascn.2004.02.002","volume":"50","author":"GBY Tee","year":"2004","unstructured":"Tee GBY, Rasool AHG, Halim AS, Rahman ARA (2004) Dependence of human forearm skin postocclusive reactive hyperemia on occlusion time. J Pharmacol Toxicol Methods 50(1):73\u201378. https:\/\/doi.org\/10.1016\/j.vascn.2004.02.002","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"2","key":"3404_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","volume":"39","author":"MC Corretti","year":"2002","unstructured":"Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol 39(2):257\u2013265. https:\/\/doi.org\/10.1016\/S0735-1097(01)01746-6","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"3404_CR32","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0735-1097(01)01657-6","volume":"38","author":"JT Kuvin","year":"2001","unstructured":"Kuvin JT, Patel AR, Sliney KA, Pandian NG, Rand WM, Udelson JE et al (2001) Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. J Am Coll Cardiol 38(7):1843\u20131849. https:\/\/doi.org\/10.1016\/S0735-1097(01)01657-6","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"3404_CR33","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4021\/cr194w","volume":"3","author":"R Ananthakrishna","year":"2012","unstructured":"Ananthakrishna R, Shankarappa RK, Rangan K, Chandrasekaran DNM (2012) Endothelial Function and Carotid Intimal Medial Thickness in Asymptomatic Subjects With and Without Cardiovascular Risk Factors. Cardiol Res 3(4):180\u2013186. https:\/\/doi.org\/10.4021\/cr194w","journal-title":"Cardiol Res"},{"issue":"4","key":"3404_CR34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1515\/dx-2020-0078","volume":"7","author":"M Franchini","year":"2020","unstructured":"Franchini M, Marano G, Cruciani M, Mengoli C, Pati I, Masiello F et al (2020) COVID-19-associated coagulopathy. Diagnosis 7(4):357\u2013363. https:\/\/doi.org\/10.1515\/dx-2020-0078","journal-title":"Diagnosis"},{"key":"3404_CR35","doi-asserted-by":"publisher","unstructured":"Elyaspour Z, Zibaeenezhad MJ, Razmkhah M, Razeghian-Jahromi I (2021) Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19. Clin Appl Thromb 27. https:\/\/doi.org\/10.1177\/10760296211042940","DOI":"10.1177\/10760296211042940"},{"key":"3404_CR36","doi-asserted-by":"publisher","unstructured":"El-Medany A, Kandoole V, Lonsdale N, Doolub G, Felekos I (2023) In-stent Thrombosis and COVID-19 Infection: Current Insights on the Mechanistic Relationship. Curr Cardiol Rev 19(1). https:\/\/doi.org\/10.2174\/1573403X18666220512142019","DOI":"10.2174\/1573403X18666220512142019"},{"issue":"6","key":"3404_CR37","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.tem.2023.03.002","volume":"34","author":"S Turner","year":"2023","unstructured":"Turner S, Khan MA, Putrino D, Woodcock A, Kell DB, Pretorius E (2023) Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol Metab 34(6):321\u2013344. https:\/\/doi.org\/10.1016\/j.tem.2023.03.002","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"3404_CR38","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/obr.12831","volume":"20","author":"J Loader","year":"2019","unstructured":"Loader J, Khouri C, Taylor F, Stewart S, Lorenzen C, Cracowski J et al (2019) The continuums of impairment in vascular reactivity across the spectrum of cardiometabolic health: A systematic review and network meta-analysis. Obes Rev 20(6):906\u2013920. https:\/\/doi.org\/10.1111\/obr.12831","journal-title":"Obes Rev"},{"issue":"9","key":"3404_CR39","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s00424-025-03103-6","volume":"477","author":"J Pourov\u00e1","year":"2025","unstructured":"Pourov\u00e1 J, Dias P, Pour M, Mlad\u011bnka P (2025) The machinery of healthy vasoconstriction: an overview. Pfl\u00fcgers Arch - Eur J Physiol 477(9):1163\u20131189. https:\/\/doi.org\/10.1007\/s00424-025-03103-6","journal-title":"Pfl\u00fcgers Arch - Eur J Physiol"},{"key":"3404_CR40","doi-asserted-by":"publisher","unstructured":"Jankowich M, Choudhary G (2020) Endothelin-1 levels and cardiovascular events. Vol. 30, Trends in Cardiovascular Medicine. Elsevier Inc., pp 1\u20138. https:\/\/doi.org\/10.1016\/j.tcm.2019.01.007","DOI":"10.1016\/j.tcm.2019.01.007"},{"issue":"7\u20138","key":"3404_CR41","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1080\/10408363.2017.1394267","volume":"54","author":"R Khaddaj Mallat","year":"2017","unstructured":"Khaddaj Mallat R, Mathew John C, Kendrick DJ, Braun AP (2017) The vascular endothelium: A regulator of arterial tone and interface for the immune system. Crit Rev Clin Lab Sci 54(7\u20138):458\u2013470. https:\/\/doi.org\/10.1080\/10408363.2017.1394267","journal-title":"Crit Rev Clin Lab Sci"},{"key":"3404_CR42","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1042\/cs0990261","volume":"99","author":"KL Berry","year":"2000","unstructured":"Berry KL, Skyrme-Jones RAMI (2000) Occlusion cuff position is an important determinant of the time course and magnitude of human brachial artery flow-mediated dilation. Clin Sci 99:261\u2013267. https:\/\/doi.org\/10.1042\/cs0990261","journal-title":"Clin Sci"},{"issue":"1","key":"3404_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/01.RES.64.1.32","volume":"64","author":"LI Sinoway","year":"1989","unstructured":"Sinoway LI, Hendrickson C, Davidson WR, Prophet S, Zelis R (1989) Characteristics of flow-mediated brachial artery vasodilation in human subjects. Circ Res 64(1):32\u201342. https:\/\/doi.org\/10.1161\/01.RES.64.1.32","journal-title":"Circ Res"},{"issue":"3","key":"3404_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/hrt.74.3.247","volume":"74","author":"KE Sorensen","year":"1995","unstructured":"Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O et al (1995) Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Heart 74(3):247\u2013253. https:\/\/doi.org\/10.1136\/hrt.74.3.247","journal-title":"Heart"},{"issue":"12","key":"3404_CR45","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/S0002-9149(98)00702-4","volume":"82","author":"B Takase","year":"1998","unstructured":"Takase B, Uehata A, Akima T, Nagai T, Nishioka T, Hamabe A et al (1998) Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol 82(12):1535\u20131539. https:\/\/doi.org\/10.1016\/S0002-9149(98)00702-4","journal-title":"Am J Cardiol"},{"issue":"2","key":"3404_CR46","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1161\/01.HYP.35.2.637","volume":"35","author":"JJ van der Heijden-Spek","year":"2000","unstructured":"van der Heijden-Spek JJ, Staessen JA, Fagard RH, Hoeks AP, Boudier HAS, Van Bortel LM (2000) Effect of Age on Brachial Artery Wall Properties Differs From the Aorta and Is Gender Dependent. Hypertension 35(2):637\u2013642. https:\/\/doi.org\/10.1161\/01.HYP.35.2.637","journal-title":"Hypertension"},{"issue":"1","key":"3404_CR47","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s10020-021-00412-1","volume":"27","author":"D Zhang","year":"2021","unstructured":"Zhang D, Li L, Chen Y, Ma J, Yang Y, Aodeng S et al (2021) Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19. Mol Med 27(1):151","journal-title":"Mol Med"},{"issue":"1","key":"3404_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41540-025-00488-z","volume":"11","author":"DLM Fonseca","year":"2025","unstructured":"Fonseca DLM, J\u00e4pel M, Gyamfi MA, Filgueiras IS, Baiochi GC, Ostrinski Y et al (2025) Dysregulated autoantibodies targeting AGTR1 are associated with the accumulation of COVID-19 symptoms. NPJ Syst Biol Appl 11(1):7. https:\/\/doi.org\/10.1038\/s41540-025-00488-z","journal-title":"NPJ Syst Biol Appl"},{"issue":"24","key":"3404_CR49","doi-asserted-by":"publisher","first-page":"5682","DOI":"10.1111\/bph.12870","volume":"171","author":"A S\u00e1nchez","year":"2014","unstructured":"S\u00e1nchez A, Mart\u00ednez P, Mu\u00f1oz M, Benedito S, Garc\u00eda-Sacrist\u00e1n A, Hern\u00e1ndez M et al (2014) Endothelin\u20101 contributes to endothelial dysfunction and enhanced vasoconstriction through augmented superoxide production in penile arteries from insulin\u2010resistant obese rats: role of ET A and ET B receptors. Br J Pharmacol 171(24):5682\u20135695. https:\/\/doi.org\/10.1111\/bph.12870","journal-title":"Br J Pharmacol"},{"issue":"33","key":"3404_CR50","doi-asserted-by":"publisher","first-page":"8512","DOI":"10.1523\/JNEUROSCI.0728-06.2006","volume":"26","author":"AG Est\u00e9vez","year":"2006","unstructured":"Est\u00e9vez AG, Sahawneh MA, Lange PS, Bae N, Egea M, Ratan RR (2006) Arginase 1 Regulation of Nitric Oxide Production Is Key to Survival of Trophic Factor-Deprived Motor Neurons. J Neurosci 26(33):8512\u20138516. https:\/\/doi.org\/10.1523\/JNEUROSCI.0728-06.2006","journal-title":"J Neurosci"},{"issue":"3","key":"3404_CR51","doi-asserted-by":"publisher","first-page":"H777","DOI":"10.1152\/ajpheart.00831.2010","volume":"300","author":"T Beleznai","year":"2011","unstructured":"Beleznai T, Feher A, Spielvogel D, Lansman SL, Bagi Z (2011) Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes. Am J Physiol Circ Physiol 300(3):H777\u2013H783. https:\/\/doi.org\/10.1152\/ajpheart.00831.2010","journal-title":"Am J Physiol Circ Physiol"},{"issue":"2","key":"3404_CR52","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/oby.20969","volume":"23","author":"FK Johnson","year":"2015","unstructured":"Johnson FK, Peyton KJ, Liu X, Azam MA, Shebib AR, Johnson RA et al (2015) Arginase promotes endothelial dysfunction and hypertension in obese rats. Obesity 23(2):383\u2013390. https:\/\/doi.org\/10.1002\/oby.20969","journal-title":"Obesity"},{"key":"3404_CR53","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ijcard.2019.11.004","volume":"301","author":"A Mahdi","year":"2020","unstructured":"Mahdi A, K\u00f6vamees O, Pernow J (2020) Improvement in endothelial function in cardiovascular disease - Is arginase the target? Int J Cardiol 301:207\u2013214. https:\/\/doi.org\/10.1016\/j.ijcard.2019.11.004","journal-title":"Int J Cardiol"},{"issue":"7","key":"3404_CR54","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00380-020-01767-x","volume":"36","author":"M Naya","year":"2021","unstructured":"Naya M, Aikawa T, Manabe O, Obara M, Koyanagawa K, Katoh C et al (2021) Elevated serum endothelin-1 is an independent predictor of coronary microvascular dysfunction in non-obstructive territories in patients with coronary artery disease. Heart Vessels 36(7):917\u2013923. https:\/\/doi.org\/10.1007\/s00380-020-01767-x","journal-title":"Heart Vessels"},{"key":"3404_CR55","doi-asserted-by":"publisher","first-page":"106476","DOI":"10.1016\/j.prostaglandins.2020.106476","volume":"151","author":"G Ozen","year":"2020","unstructured":"Ozen G, Aljesri K, Celik Z, Turky\u0131lmaz G, Turky\u0131lmaz S, Teskin O et al (2020) Mechanism of thromboxane receptor-induced vasoconstriction in human saphenous vein. Prostaglandins Other Lipid Mediat 151:106476. https:\/\/doi.org\/10.1016\/j.prostaglandins.2020.106476","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"3404_CR56","doi-asserted-by":"publisher","first-page":"174435","DOI":"10.1016\/j.ejphar.2021.174435","volume":"909","author":"J Hu","year":"2021","unstructured":"Hu J, Yang Z, Chen X, Kuang S, Lian Z, Ke G et al (2021) Thromboxane A2 is involved in the development of hypertension in chronic kidney disease rats. Eur J Pharmacol 909:174435. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174435","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"3404_CR57","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1161\/01.STR.19.9.1145","volume":"19","author":"CT Stier","year":"1988","unstructured":"Stier CT, Benter IF, Levine S (1988) Thromboxane A2 in severe hypertension and stroke in stroke-prone spontaneously hypertensive rats. Stroke 19(9):1145\u20131150. https:\/\/doi.org\/10.1161\/01.STR.19.9.1145","journal-title":"Stroke"},{"key":"3404_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2011.00024","author":"J Stitham","year":"2011","unstructured":"Stitham J, Midgett C, Martin KA, Hwa J (2011) Prostacyclin: An Inflammatory Paradox. Front Pharmacol. 210.3389\/fphar.2011.00024","journal-title":"Front Pharmacol"},{"key":"3404_CR59","doi-asserted-by":"publisher","unstructured":"Patrono C, Rocca B (2019) Measurement of Thromboxane Biosynthesis in Health and Disease. Front Pharmacol 10. https:\/\/doi.org\/10.3389\/fphar.2019.01244","DOI":"10.3389\/fphar.2019.01244"},{"issue":"1","key":"3404_CR60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2011.02.044","volume":"216","author":"Y Shahin","year":"2011","unstructured":"Shahin Y, Khan JA, Samuel N, Chetter I (2011) Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: A meta-analysis of randomised controlled trials. Atherosclerosis 216(1):7\u201316. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.02.044","journal-title":"Atherosclerosis"},{"issue":"2","key":"3404_CR61","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000375259","volume":"131","author":"J-D Chen","year":"2015","unstructured":"Chen J-D, Liu M, Chen X, Yang Z-J (2015) Effect of angiotensin receptor blockers on flow-mediated vasodilation: a meta-analysis of randomized controlled trials. Cardiology 131(2):69\u201379. https:\/\/doi.org\/10.1159\/000375259","journal-title":"Cardiology"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03404-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03404-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03404-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:32:21Z","timestamp":1791667941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03404-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,10]]},"references-count":61,"alternative-id":["3404"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03404-2","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,10]]},"assertion":[{"value":"13 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Signed informed consent was obtained from all involved persons.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Protocol \u2116 59 from June 05, 2020, of the Bioethics Commission of the I. Horbachevsky Ternopil National Medical University.","order":3,"name":"Ethics","label":"Institutional review board","group":{"name":"EthicsHeading","label":"Declarations"}}]}}